disrupt 发表于 2025-3-26 22:06:05

Submitted on: 04 August 2003.
Revised on: 18 October 2003.
Accepted on: 11 December 2003.

___________________DRUGS & THERAPY PERSPECTIVES---SPRINGERNATURE

Obituary 发表于 2025-3-27 02:57:44

http://reply.papertrans.cn/1/77/7676/7676-32.png

同谋 发表于 2025-3-27 09:09:03

http://reply.papertrans.cn/1/77/7676/7676-33.png

大都市 发表于 2025-3-27 12:38:53

Submitted on: 26 March 2006.
Revised on: 25 June 2006.
Accepted on: 07 July 2006.

___________________DRUGS & THERAPY PERSPECTIVES---SPRINGERNATURE

的阐明 发表于 2025-3-27 14:24:19

Submitted on: 01 August 2017.
Revised on: 11 November 2017.
Accepted on: 14 December 2017.

___________________DRUGS & THERAPY PERSPECTIVES---SPRINGERNATURE

使声音降低 发表于 2025-3-27 20:20:13

http://reply.papertrans.cn/1/77/7676/7676-36.png
页: 1 2 3 [4]
查看完整版本: ESCI期刊DRUGS & THERAPY PERSPECTIVES 2024/2025影响因子:0.694 (DRUGS THER PERSPECT) (1172-0360). (PHARMACOLOGY & PHARMACY)(药理学